EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The persistent chasm between PrEP awareness and uptake: characterizing the biomedical HIV prevention continuum in a nationwide cohort of transgender women in the United States and Puerto Rico

Erin E Cooney iD, Tonia C Poteat iD, Meg Stevenson iD, Asa E Radix iD, Annick Borquez, Keri N Althoff, Sabriya Linton, Ceza Pontes, Chris Beyrer, Arianna Lint, Marissa Miller, Carter Brown und 8 weitere

Journal of the International AIDS Society · 2025-12 · 28 (12)

DOI: 10.1002/jia2.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the International AIDS Society, online erschienen am 18.12.2025. Verfasst von Erin E Cooney und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Transgender Persons, HIV Infections, Pre-Exposure Prophylaxis, Anti-HIV Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Enhanced Cohort Methods for HIV Research and Epidemiology (ENCORE), NIAID NIH HHS, Emory University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Transgender (trans) women are disproportionately impacted by HIV, yet data on the biomedical HIV PrEP continuum (HIVPC) among trans women are limited. We characterized the HIVPC among a large, nationwide cohort of trans women in the United States and Puerto Rico by pre‐exposure prophylaxis (PrEP) modality (daily oral and long‐acting injectable, LAI) and identified correlates of uptake and non‐adherence.

Methods

From April 2023 to December 2024, we enrolled English and Spanish‐speaking adult trans women (age 18 years or older) not living with HIV (laboratory‐confirmed via fourth‐generation HIV‐1/2 antigen/antibody testing) and residing in the United States and Puerto Rico into the cohort. PrEP data were collected via self‐administered surveys. We characterized the HIVPC using descriptive statistics and assessed for differences in proportions for each step of the HIVPC by modality. Modified Poisson regression models estimated adjusted prevalence ratios (aPR) and 95% confidence intervals (95% CI) for correlates of HIVPC step (e.g. awareness to uptake).

Results

We enrolled 2504 participants, 1636 (65%) of whom may have benefitted from PrEP based on self‐reported sexual history and/or needle sharing in the prior 6 months at baseline. Forty‐two percent were 18–29 years old, 18% identified as Hispanic and/or Latina/x/e and 13% identified as Black (inclusive of multiracial participants). Among participants who may have benefitted from PrEP, 92% ( n = 1495) had ever heard of PrEP, 36% ( n = 591) had ever used PrEP, 27% ( n = 441) had recently used PrEP (past 6 months) and 20% ( n = 330) were adherent. The largest proportional difference in HIVPC step was from awareness to uptake (60% of PrEP‐aware participants had never used PrEP). This difference was significantly greater for LAI PrEP (96% of LAI PrEP‐aware participants had never used LAI). Correlates of PrEP uptake included high perceived HIV acquisition risk (aPR = 2.08, 95% CI = 1.59−2.72; ref = no perceived risk), current use of exogenous oestrogen and/or anti‐androgens (aPR = 1.47 95% CI = 1.21−1.79), and receipt of health services at an LGBTQ+ clinic (aPR = 1.34, 95% CI = 1.16−1.55). Correlates of non‐adherence among PrEP users included being a non‐U.S. citizen (aPR: 2.41, 95% CI = 1.44−4.05) and recent food insecurity (aPR: 1.47, 95% CI = 1.04−2.06).

Conclusions

Interventions to improve HIVPC outcomes—especially PrEP uptake—are needed to optimize HIV PrEP among trans women. PrEP interventions may need to include individually tailored, integrated programming to address risk perception, nutrition, gender‐affirming care and comprehensive health, social, and legal needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsHIV InfectionsPre-Exposure ProphylaxisAnti-HIV AgentsHealth Knowledge, Attitudes, PracticeHumansFemalePuerto RicoAdultUnited StatesYoung AdultMaleAdolescentCohort StudiesMiddle Aged

Stichwörter der Autor:innen

HIV preventionadherencepre‐exposure prophylaxistransgender womenuptake

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Center for Public Health and Human Rights, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Duke University School of Nursing, Durham, North Carolina, USA.
  • Callen-Lorde Community Health Center, New York, New York, USA.
  • Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
  • Division of Infectious Diseases & Global Public Health, UC San Diego, La Jolla, California, USA.

ORCID-Profile: Erin E Cooney, Tonia C Poteat, Meg Stevenson, Asa E Radix, Vani Vannappagari, Andrea L Wirtz

Förderung

  • The Enhanced Cohort Methods for HIV Research and Epidemiology (ENCORE)
  • NIAID NIH HHS
  • Emory University
  • the Centers for AIDS Research (CFAR)
  • the University of Miami
  • including Johns Hopkins University
  • NICHD/NIAID/NIAAA
  • Duke University

Zitieren

APA

Cooney, E. E., Poteat, T. C., Stevenson, M., Radix, A. E., Borquez, A., Althoff, K. N., Linton, S., Pontes, C., Beyrer, C., Lint, A., Miller, M., Brown, C., Wawrzyniak, A. J., Brown, C. A., Ragone, L., Vannappagari, V., Guignard, A., Reisner, S. L., Wirtz, A. L., & ENCORE Study Group (2025). The persistent chasm between PrEP awareness and uptake: characterizing the biomedical HIV prevention continuum in a nationwide cohort of transgender women in the United States and Puerto Rico. Journal of the International AIDS Society, 28(12). https://doi.org/10.1002/jia2.70070

Vancouver

Cooney EE, Poteat TC, Stevenson M, Radix AE, Borquez A, Althoff KN, et al. The persistent chasm between PrEP awareness and uptake: characterizing the biomedical HIV prevention continuum in a nationwide cohort of transgender women in the United States and Puerto Rico. Journal of the International AIDS Society. 2025;28(12). doi:10.1002/jia2.70070

BibTeX
@article{Cooney2025,
  author = {Cooney, Erin E and Poteat, Tonia C and Stevenson, Meg and Radix, Asa E and Borquez, Annick and Althoff, Keri N and Linton, Sabriya and Pontes, Ceza and Beyrer, Chris and Lint, Arianna and Miller, Marissa and Brown, Carter and Wawrzyniak, Andrew J and Brown, Carolyn A and Ragone, Leigh and Vannappagari, Vani and Guignard, Adrienne and Reisner, Sari L and Wirtz, Andrea L and ENCORE Study Group, ENCORE Study Group},
  title = {The persistent chasm between PrEP awareness and uptake: characterizing the biomedical HIV prevention continuum in a nationwide cohort of transgender women in the United States and Puerto Rico},
  journal = {Journal of the International AIDS Society},
  year = {2025},
  volume = {28},
  number = {12},
  doi = {10.1002/jia2.70070}
}
Kostenlos starten →